Skip to content

Diagnosis of Transient Tachypnea of Newborn

Thoracic Fluid Content Using Electrical Cardiometry Versus Lung Ultrasound in the Diagnosis of Transient Tachypnea of Newborn

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05538780
Enrollment
50
Registered
2022-09-14
Start date
2022-01-01
Completion date
2023-01-01
Last updated
2022-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient Tachypnea of the Newborn

Brief summary

Transient tachypnea of the newborn (TTN) is the most common cause of respiratory distress in fullterm newborn. TTN is a diagnosis of exclusion, It is primarily diagnosed based on medical history and typical clinical presentation. Lung ultrasonography is an accurate, non invasive and reliable tool for diagnosing TTN. Cardiometry is presently the only tool to evaluate thoracic fluid content continuously and noninvasively at the bedside.

Interventions

None listed

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Days to 3 Days
Healthy volunteers
No

Inclusion criteria

* fifty newborns with gestational age ≥ 34 weeks (calculated from the first day of last menstrual period and using New Ballard score) diagnosed with TTN

Exclusion criteria

1. Gestational age less than 34 weeks. 2. Major congenital abnormalities. 3. Congenital heart diseases. 4. Neonatal sepsis. 5. Neonatal pneumonia. 6. Other causes of respiratory distress (RD)

Design outcomes

Primary

MeasureTime frameDescription
change of thoracic fluid contentat enrollment and after 72 hours of birthmeasured by electrical cardiometry ( ICON®; Osypka Medical, Berlin, Germany)
change of ultrasound data: double-lung point, interstitial lung syndrome, and fuzziness of the pleural lines (A-lines) and pleural effusion.at enrollment and after 72 hours of birthusing Siemens Acuson X300 ultrasound machine ( Siemens Health Care GmbH, Erlangen, Germany )

Countries

Egypt

Contacts

Primary Contactashraf abuhamama, PhD
ashraf.abohamama@med.tanta.edu.eg0020403322645

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026